Cardiff Oncology Inc (CRDF) stock news · rev $593.0K
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
This CRDF news page leads with what Cardiff Oncology Inc filed — not a scraped headline mill.
No cached 8-K sentence for CRDF yet. We will not pad this page with generic market recap.
Latest reported CRDF revenue for 2025-12-31 was $593.0K. Net income was -$45.9M. Revenue was down 13.2% from 2024-12-31 to 2025-12-31. CRDF currently screens at market cap $238.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CRDF stock page; for the tape open the quote page.
CRDF stock news FAQ
What are CRDF's latest revenue and net income?
Latest cached Cardiff Oncology Inc (CRDF) revenue for Dec 31, 2025 was $593.0K. Net income was -$45.9M. Statements: https://lician.com/financials/crdf
How did CRDF revenue change from the prior cached period?
Cached Cardiff Oncology Inc (CRDF) revenue was down 13.2% from $683.0K (Dec 31, 2024) to $593.0K (Dec 31, 2025). Statements: https://lician.com/financials/crdf
What is CRDF's market cap?
Cardiff Oncology Inc (CRDF) market cap is $238.8M on the latest cached fundamentals snapshot.
What kind of company is CRDF?
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Where is CRDF stock news listed?
Cached stock news for Cardiff Oncology Inc (CRDF) is listed at https://lician.com/news/crdf. Filings: https://lician.com/sec/crdf
Not investment advice.